Notice of Stock Split and Partial Revision to the Articles of Incorporation Following the Split
Notice of Change in Use of Funds
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2024 (Nine Months Ended December 31, 2023)
(Disclosure Progress Report) Notice of Acquisition of K SHIP Co., Ltd. (Making it a Consolidated Subsidiary)
Results of Joint Research with Itoigawa General Hospital Using the REZULT Medical Big Data Platform Study of Headache Treatment Patterns
Demonstration Trial Starts for Use of Generative AI at the iBss Call Center
Notice of Transition to the Company with an Audit & Supervisory Committee System
Notice of Change in Managing Director of the Overseas Subsidiary
Provision of Medical Big Data for Osaka Metropolitan University Analysis of the Relationship between Outings During the Pandemic and Lifestyle Disease Medical Expenses
FY2024.3 Financial Results Briefing for the 2nd Quarter